Automated Insulin for Management of Intrapartum Glycemia

Recruiting now · Not applicable

Conditions studied: Type 1 Diabetes (T1D), Pregnancy, Pre-Gestational Diabetes

In brief

The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.

Key facts

Study ID
NCT06883344
Run by
University of California, San Francisco
People needed
150
Starts
2025-12-05
Expected to finish
2028-12-31
Last updated by the study team
2026-07-13

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.